美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Therapeutics

33.58

-0.1500-0.44%

盤後：33.580.00000.00%18:33 EDT

成交量：12.07萬

成交額：410.08萬

市值：9.45億

市盈率：-18.98

高：34.90

開：33.71

低：33.51

收：33.73

資料載入中...

總覽公司新聞公告

Crispr Therapeutics Ag7月1日成交額為1.67億美元

Carisma Therapeutics, Inc.7月1日成交額為45.01萬美元

Black Diamond Therapeutics, Inc.盤中異動股價大漲5.44%

Heron Therapeutics, Inc.盤中異動股價大漲5.07%報2.18美元

Leap Therapeutics, Inc.盤中異動快速跳水5.76%報0.280美元

【艾伯維(ABBV.US)斥資21億美元收購臨牀階段生物技術公司Capstan Therapeutics】智通財經APP

艾伯維擬以高達21億美元收購細胞療法開發商Capstan

Carisma Therapeutics, Inc.6月30日成交額為46.79萬美元

Aptevo Therapeutics Inc.6月30日成交額為111.20萬美元

Nektar Therapeutics股價在宣佈公開發行後下跌

Arcturus Therapeutics股價因OTC缺乏症試驗數據積極而上漲

【嘉和生物-B(06998.HK)：首批患者已接受TCE給藥且耐受性良好】智通財經APP訊，嘉和生物-B(06998.H

艾伯維將以高達21億美元收購Capstan Therapeutics

环球市场播报

Black Diamond Therapeutics, Inc.盤中異動早盤股價大漲5.11%報2.47美元

Unicycive Therapeutics, Inc.股價重挫17.47% 市值跌1251.78萬美元

Vyne Therapeutics Inc.6月27日成交額為189.83萬美元

Neumora Therapeutics, Inc.6月27日成交額為825.20萬美元

Kazia Therapeutics Limited6月27日成交額為37.42萬美元

Galectin Therapeutics Inc.6月27日成交額為459.49萬美元

Jasper Therapeutics, Inc.盤中異動臨近收盤股價大跌5.89%報5.36美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LENZ/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":33.58,"timestamp":1753128000000,"preClose":33.73,"halted":0,"volume":120678,"hourTrading":{"tag":"盘后","latestPrice":33.58,"preClose":33.58,"latestTime":"18:33 EDT","volume":2101,"amount":70564.31,"timestamp":1753137190763},"delay":0,"floatShares":12729900,"shares":28146154,"eps":-1.769251,"marketStatus":"已收盤","change":-0.15,"latestTime":"07-21 16:00:00 EDT","open":33.71,"high":34.8988,"low":33.505,"amount":4100846.9715839997,"amplitude":0.041322,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1753171200000},"marketStatusCode":5,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":33.73,"postHourTrading":{"tag":"盘后","latestPrice":33.58,"preClose":33.58,"latestTime":"18:33 EDT","volume":2101,"amount":70564.31,"timestamp":1753137190763},"volumeRatio":0.380418,"impliedVol":0.9395,"impliedVolPercentile":0.8571},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":12729900,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.380418,"shares":28146154,"dividePrice":0,"high":34.8988,"amplitude":0.041322,"preClose":33.73,"low":33.505,"week52Low":16.535,"pbRate":"4.92","week52High":38.93,"institutionHeld":0,"latestPrice":33.58,"eps":-1.769251,"divideRate":0,"volume":120678,"delay":0,"ttmEps":-1.769251,"open":33.71,"prevYearClose":28.87,"prevWeekClose":33.73,"prevMonthClose":29.31,"prevQuarterClose":29.31,"fiveDayClose":33.73,"twentyDayClose":29.94,"sixtyDayClose":26.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548378878","title":"Crispr Therapeutics Ag7月1日成交額為1.67億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548378878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548378878?lang=zh_tw&edition=fundamental","pubTime":"2025-07-02 09:40","pubTimestamp":1751420401,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Crispr Therapeutics Ag成交额为1.67亿美元，成交额较昨日减少35.81%，当日成交量为344.82万股。Crispr Therapeutics Ag于2025年7月1日跌0.27%，报48.51美元，该股过去5个交易日涨3.7%，年初至今涨23.25%，过去60日涨48.53%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702094003a7296abe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702094003a7296abe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LU1861559042.SGD","BK4588","BK4611","LENZ","LU1861558580.USD","BK4556","CRSP","BK4585","BK4007","BK4139"],"gpt_icon":0},{"id":"2548832748","title":"Carisma Therapeutics, Inc.7月1日成交額為45.01萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548832748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548832748?lang=zh_tw&edition=fundamental","pubTime":"2025-07-02 09:27","pubTimestamp":1751419625,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Carisma Therapeutics, Inc.成交额为45.01万美元，成交额较昨日减少3.79%，当日成交量为115.27万股。Carisma Therapeutics, Inc.于2025年7月1日涨3.4%，报0.405美元，该股过去5个交易日跌5.4%，年初至今跌3.37%，过去60日涨110.89%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092709a72962c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092709a72962c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2548889772","title":"Black Diamond Therapeutics, Inc.盤中異動 股價大漲5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548889772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548889772?lang=zh_tw&edition=fundamental","pubTime":"2025-07-02 01:26","pubTimestamp":1751390788,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日01时26分，Black Diamond Therapeutics, Inc.股票出现波动，股价大幅上涨5.44%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Lixte Biotechnology Holdings, Inc.、Neurogene Inc.涨幅较大，Oragenics Inc.、Soligenix, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1939.53%、1431.32%、269.92%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Neurogene Inc.，振幅分别为69.61%、55.78%、43.68%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070201262897962aa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070201262897962aa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BDTX","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2548988959","title":"Heron Therapeutics, Inc.盤中異動 股價大漲5.07%報2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548988959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548988959?lang=zh_tw&edition=fundamental","pubTime":"2025-07-02 01:02","pubTimestamp":1751389330,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日01时02分，Heron Therapeutics, Inc.股票出现异动，股价大幅拉升5.07%。截至发稿，该股报2.18美元/股，成交量95.8445万股，换手率0.63%，振幅6.28%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurogene Inc.、Adial Pharmaceuticals, Inc涨幅较大，Oragenics Inc.、Soligenix, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1933.51%、1423.95%、214.05%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Soligenix, Inc.，振幅分别为69.61%、55.78%、43.51%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702010210a728d605&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702010210a728d605&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","HRTX","BK4139","BK4539"],"gpt_icon":0},{"id":"2548025780","title":"Leap Therapeutics, Inc.盤中異動 快速跳水5.76%報0.280美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548025780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548025780?lang=zh_tw&edition=fundamental","pubTime":"2025-07-01 21:34","pubTimestamp":1751376841,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日21时34分，Leap Therapeutics, Inc.股票出现波动，股价快速下挫5.76%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics Inc 是一家生物制药公司，开发新型生物标志物靶向抗体疗法，旨在通过抑制基本的肿瘤促进途径、靶向癌症特异性细胞表面分子和利用免疫系统攻击癌细胞来治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701213401a4c91aae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701213401a4c91aae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4505","BK4139","BK4563","BK4539","LENZ","LPTX"],"gpt_icon":0},{"id":"2548028205","title":"【艾伯維(ABBV.US)斥資21億美元收購臨牀階段生物技術公司Capstan Therapeutics】智通財經APP","url":"https://stock-news.laohu8.com/highlight/detail?id=2548028205","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548028205?lang=zh_tw&edition=fundamental","pubTime":"2025-07-01 10:42","pubTimestamp":1751337770,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1430594728.SGD","LU0661504455.SGD","IE0009355771.USD","LU0708994859.HKD","IE0002270589.USD","IE00BVYPNW00.USD","LU0820561818.USD","LU1003077747.HKD","LU1061106388.HKD","LU1074936037.SGD","LU0029864427.USD","LU2237443465.HKD","SG9999001440.SGD","LU2089283258.USD","LU0114720955.EUR","LU1496350502.SGD","LU1162221912.USD","LU0203347892.USD","LENZ","LU1291159041.SGD","IE0002141913.USD","SG9999011175.SGD","IE00BSNM7G36.USD","LU2237443549.SGD","SG9999015978.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU1934455863.HKD","LU2468319806.SGD","IE00BDGV0183.EUR","LU1244550494.USD","LU0417517546.SGD","LU1989772840.SGD","LU0310799852.SGD","IE00BJJMRZ35.SGD","SG9999015945.SGD","LU2129689431.USD","LU0795875086.SGD","LU0882574055.USD","SG9999015986.USD","LU1718418525.SGD","BK4139","IE00B42XCP33.USD","ABBV","LU0545039389.USD","LU1496350171.SGD","BK4534","LU1267930490.SGD","LU1037948541.HKD","LU0795875169.SGD"],"gpt_icon":0},{"id":"2548040403","title":"艾伯維擬以高達21億美元收購細胞療法開發商Capstan","url":"https://stock-news.laohu8.com/highlight/detail?id=2548040403","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548040403?lang=zh_tw&edition=fundamental","pubTime":"2025-07-01 10:08","pubTimestamp":1751335681,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["01477","LENZ","BK4022","BK4230","BK1191","BK4007","BK1574","CAR","BK4139","BK4539"],"gpt_icon":0},{"id":"2548042270","title":"Carisma Therapeutics, Inc.6月30日成交額為46.79萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548042270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548042270?lang=zh_tw&edition=fundamental","pubTime":"2025-07-01 09:25","pubTimestamp":1751333141,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，Carisma Therapeutics, Inc.成交额为46.79万美元，成交额较昨日增加29.51%，当日成交量为118.94万股。Carisma Therapeutics, Inc.于2025年6月30日跌2.25%，报0.392美元，该股过去5个交易日跌13.17%，年初至今跌6.54%，过去60日涨76.4%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092547a7272ee1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092547a7272ee1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2548004217","title":"Aptevo Therapeutics Inc.6月30日成交額為111.20萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548004217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548004217?lang=zh_tw&edition=fundamental","pubTime":"2025-07-01 09:16","pubTimestamp":1751332611,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，Aptevo Therapeutics Inc.成交额为111.20万美元，成交额较昨日增加15.62%，当日成交量为37.29万股。Aptevo Therapeutics Inc.于2025年6月30日跌0.97%，报3.05美元，该股过去5个交易日跌6.15%，年初至今跌96.46%，过去60日跌88.95%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-30|111.20万|15.62%|37.29万|#|2025-06-27|96.17万|-27.11%|30.82万|#|2025-06-26|131.95万|-11.81%|40.96万|#|2025-06-25|149.61万|-65.50%|45.85万|#|2025-06-24|433.61万|-5.77%|119.35万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司，专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701091704a4c7ae05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701091704a4c7ae05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BK4539","APVO"],"gpt_icon":0},{"id":"2548046905","title":"Nektar Therapeutics股價在宣佈公開發行後下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2548046905","media":"英为财情","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548046905?lang=zh_tw&edition=fundamental","pubTime":"2025-07-01 04:17","pubTimestamp":1751314620,"startTime":"0","endTime":"0","summary":"Investing.com --  Nektar Therapeutics  股价下跌3%，此前这家临床阶段生物技术公司宣布已开始进行其普通股和预付权证的承销公开发行。Nektar还计划授予承销商30天期权，以购买最多额外15%的股份，价格为公开发行价格，减去承销折价和佣金。Nektar打算将此次发行所得款项用于一般公司用途，包括研发、临床开发和制造成本，以支持其药物候选产品的推进。公开发行的宣布通常会导致现有股东持股被稀释，这似乎引发了Nektar股价下跌2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cn.investing.com/news/stock-market-news/article-93CH-2866899","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["BK4007","LENZ","BK4139","BK4539"],"gpt_icon":1},{"id":"2548014494","title":"Arcturus Therapeutics股價因OTC缺乏症試驗數據積極而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2548014494","media":"英为财情","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548014494?lang=zh_tw&edition=fundamental","pubTime":"2025-06-30 23:20","pubTimestamp":1751296800,"startTime":"0","endTime":"0","summary":"Investing.com -- Arcturus Therapeutics Holdings Inc 股价上涨2%，此前该公司两项针对鸟氨酸转氨甲酰酶缺乏症的ARCT-810 mRNA疗法的第2期临床试验取得积极中期结果。该公司报告称，ARCT-810在两项研究中均显示出显著的生物学效应，包括持续降低并使升高的谷氨酰胺水平正常化，谷氨酰胺是尿素循环功能的重要生物标志物。美国开放标签研究中的所有三名参与者在接受前三剂治疗后谷氨酰胺水平持续下降并达到正常水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cn.investing.com/news/stock-market-news/article-93CH-2866623","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Arcturus Therapeutics股价因OTC缺乏症试验数据积极而上涨","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2547018650","title":"【嘉和生物-B(06998.HK)：首批患者已接受TCE給藥且耐受性良好】智通財經APP訊，嘉和生物-B(06998.H","url":"https://stock-news.laohu8.com/highlight/detail?id=2547018650","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547018650?lang=zh_tw&edition=fundamental","pubTime":"2025-06-30 22:29","pubTimestamp":1751293778,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","06998","BK1583","BK4007","BK4139","BK4539","BK1574","BK1161"],"gpt_icon":0},{"id":"2547001853","title":"艾伯維將以高達21億美元收購Capstan Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2547001853","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547001853?lang=zh_tw&edition=fundamental","pubTime":"2025-06-30 22:27","pubTimestamp":1751293620,"startTime":"0","endTime":"0","summary":"美国制药商艾伯维周一表示，将以高达 21 亿美元的现金交易收购细胞疗法开发商 Capstan Therapeutics。\n　　Capstan 公司研发 CAR-T 疗法，这是一种利用患者自身免疫细胞（特别是 T 细胞）来对抗疾病的治疗方式。其主要药物 CPTX2309 目前正处于自身免疫性疾病治疗的研发阶段。\n　　自去年其重磅关节炎药物修美乐（Humira）失去专利保护以来，艾伯维一直专注于拓展其研发管线。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-06-30/doc-infcwksa9652968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4539","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2547097536","title":"Black Diamond Therapeutics, Inc.盤中異動 早盤股價大漲5.11%報2.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547097536?lang=zh_tw&edition=fundamental","pubTime":"2025-06-30 21:43","pubTimestamp":1751290989,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时43分，Black Diamond Therapeutics, Inc.股票出现异动，股价大幅拉升5.11%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2217.94%、131.89%、74.70%，振幅较大的相关个股有Artelo Biosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Eyenovia, Inc.，振幅分别为79.51%、34.23%、26.93%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630214310a726485d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630214310a726485d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2547092781","title":"Unicycive Therapeutics, Inc.股價重挫17.47% 市值跌1251.78萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547092781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547092781?lang=zh_tw&edition=fundamental","pubTime":"2025-06-30 21:32","pubTimestamp":1751290341,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时32分，Unicycive Therapeutics, Inc.股票出现波动，股价急速跳水17.47%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Eyenovia, Inc.涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2079.66%、114.03%、61.93%，振幅较大的相关个股有Artelo Biosciences, Inc.、Eyenovia, Inc.、Exicure, Inc.，振幅分别为43.74%、19.21%、16.13%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家致力于开发某些医疗条件治疗方法的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213221a4c6c4ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213221a4c6c4ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","UNCY","LENZ","BK4139"],"gpt_icon":0},{"id":"2546615771","title":"Vyne Therapeutics Inc.6月27日成交額為189.83萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546615771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546615771?lang=zh_tw&edition=fundamental","pubTime":"2025-06-28 14:56","pubTimestamp":1751093779,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Vyne Therapeutics Inc.成交额为189.83万美元，成交额较昨日减少76.67%，当日成交量为123.81万股。Vyne Therapeutics Inc.于2025年6月27日跌12.35%，报1.42美元，该股过去5个交易日涨59.55%，年初至今跌57.61%，过去60日跌7.19%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-27|189.83万|-76.67%|123.81万|#|2025-06-26|813.80万|-22.31%|497.75万|#|2025-06-25|1047.51万|855.99%|753.71万|#|2025-06-24|109.57万|661.07%|110.01万|#|2025-06-23|14.40万|-61.67%|15.89万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628145620a4c2995b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628145620a4c2995b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2546775205","title":"Neumora Therapeutics, Inc.6月27日成交額為825.20萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546775205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546775205?lang=zh_tw&edition=fundamental","pubTime":"2025-06-28 12:02","pubTimestamp":1751083371,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Neumora Therapeutics, Inc.成交额为825.20万美元，成交额较昨日增加1414.91%，当日成交量为1085.40万股。Neumora Therapeutics, Inc.于2025年6月27日跌5.32%，报0.757美元，该股过去5个交易日跌3.7%，年初至今跌92.86%，过去60日跌17.1%。该公司已扩大其治疗产品线，目前包括七个临床和临床前神经科学项目，旨在针对一系列未得到充分治疗的神经精神障碍和神经退行性疾病的新型作用机制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628120300a7220aa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628120300a7220aa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","NMRA","BK4007","BK4139"],"gpt_icon":0},{"id":"2546775350","title":"Kazia Therapeutics Limited6月27日成交額為37.42萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546775350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546775350?lang=zh_tw&edition=fundamental","pubTime":"2025-06-28 11:07","pubTimestamp":1751080035,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Kazia Therapeutics Limited成交额为37.42万美元，成交额较昨日增加320.12%，当日成交量为6.02万股。Kazia Therapeutics Limited于2025年6月27日跌2.99%，报6.34美元，该股过去5个交易日跌30.77%，年初至今跌28.42%，过去60日涨58.97%。该集团正在开发一种潜在的治疗胶质母细胞瘤的药物paxalisib；用于治疗卵巢癌的Cantrixil；和一些其他药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628110717a4c25459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628110717a4c25459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZIA","LENZ","BK4139","BK4007","NVGNF","BK4539"],"gpt_icon":0},{"id":"2546735987","title":"Galectin Therapeutics Inc.6月27日成交額為459.49萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546735987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546735987?lang=zh_tw&edition=fundamental","pubTime":"2025-06-28 10:09","pubTimestamp":1751076542,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Galectin Therapeutics Inc.成交额为459.49万美元，成交额较昨日增加279.56%，当日成交量为194.67万股。Galectin Therapeutics Inc.于2025年6月27日跌0.85%，报2.33美元，该股过去5个交易日跌3.72%，年初至今涨80.62%，过去60日涨84.92%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-27|459.49万|279.56%|194.67万|#|2025-06-26|121.06万|63.43%|49.96万|#|2025-06-25|74.07万|-43.30%|29.37万|#|2025-06-24|130.65万|-46.49%|54.57万|#|2025-06-23|244.16万|-78.05%|97.77万|Galectin Therapeutics Inc是一家临床阶段生物制药公司。公司的galectin-3 抑制剂是belapectin ，在临床前模型中已被证明可以逆转肝纤维化和肝硬化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628100904a721e675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628100904a721e675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","GALT"],"gpt_icon":0},{"id":"2546729951","title":"Jasper Therapeutics, Inc.盤中異動 臨近收盤股價大跌5.89%報5.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546729951?lang=zh_tw&edition=fundamental","pubTime":"2025-06-28 03:50","pubTimestamp":1751053815,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时50分，Jasper Therapeutics, Inc.股票出现异动，股价急速下挫5.89%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Eyenovia, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、天境生物涨幅较大，Inmune Bio Inc.、Hcw Biologics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为245.53%、168.76%、137.57%，振幅较大的相关个股有Inmune Bio Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Channel Therapeutics Corporation，振幅分别为105.57%、74.75%、64.91%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035015a7217370&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035015a7217370&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","JSPR","BK4139","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"盤前","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742443200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-07-18","current":-20.381494,"percent":0.009677,"low":-20.747029,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"high":-5.069183,"avg":-11.412713,"sd":4.103005,"marketCap":973012543},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543}],"updateTime":1753151889077}}}